»ÆÉ«Ö±²¥

Pfizer, Lung Health Foundation (LHF), Lung Cancer Canada (LCC), and the Quebec Lung Association (QLA) are collaborating to offer a new grant opportunity seeking proposals for quality improvement initiatives focused on improving the care of outcomes of Canadians living with metastatic non-small cell lung cancer (NSCLC) with special focus on improving health equity in this setting.

Pfizer, LHF, LCC and QLA (‘the collaborators’) are jointly issuing this Request for Proposal (RFP). Grant funding and general oversight of the funded projects will be provided directly from Pfizer on behalf of Pfizer and the collaborators.

For all grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. The collaborators must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the project. 

Date RFP Issued: April 4, 2023
Geographic Scope: Canada
Clinical Area: Metastatic non-small cell lung cancer (NSCLC)
Link to full RFP:
Specific Area of Interest: Topics of highlighted interest include, but are not limited to:

• Improving health equity in metastatic NSCLC by addressing disparities for patients marginalized due to age, race, geography, income or other factors
• Implementation of value-based healthcare to improve quality of care for patients (project example: )
• Encouraging the use of multidisciplinary care models (e.g., nurse navigator, palliative care, psychological/mental health support)

Approaches to optimize care throughout the cancer patient experience, including optimal access to clinical trials and evidence-based treatment

Refer to complete details in the . If you have questions regarding this RFP, please direct them in writing to Jennifer Schreiber, Grant Officer (jennifer.schreiber@pfizer.com).

Deadlines

Internal: May 16, 2023 at 4:30pm. Contact the grants facilitator for your faculty. For additional resources, click here for guidance on internal deadlines and submission processes.

Funder: May 30, 2023 at 11:59pm EST